循環器内科 Twitter アカウントlanguage English

英文原著論文 "2019" Original Papers in English

緑色のタイトル部分をクリックすると、論文PDFが表示されます。

【 2019 年 】（IF: 2018 年）

  1. Konno R, Tatebe S, Sugimura K, Satoh K, Aoki T, Miura M, Suzuki H, Yamamoto S, Sato H, Terui Y, Miyata S, Adachi O, Kimura M, Saiki Y, Shimokawa H. Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease. PLOS ONE. 4(11):e0225403,2019. (IF=2.776)

  2. Nishihira K, Kojima S, Takegami M, Honda S, Nakao Y, Takahashi J, Itoh T, Watanabe T, Morimasa M, Shimokawa H, Sumiyoshi T, Kimura K, Yasuda S. Clinical Characteristics and In-Hospital Mortality According to Left Main and Non-Left Main Culprit Lesions: Report from the Japan Acute Myocardial Infarction Registry (JAMIR). Circ Rep. 1:601-609,2019.

  3. Kikuchi N, Satoh K, Satoh T, Yaoita N, Siddique MAH, Omura J, Kurosawa R, Nogi M, Sunamura S, Miyata S, Misu H, Saito Y, Shimokawa H. Diagnostic and prognostic significance of serum levels of selenoprotein P in patients with pulmonary hypertension. Arterioscler Thromb Vasc Biol. 39:2553-2562,2019. (IF=6.618)

  4. Kikuchi Y, Takahashi J, Hao K, Suda A, Shindo T, Ikeda S, Shiroto T, Matsumoto Y, Miyata S, Sakata Y, Shimokawa H. Usefulness of intracoronary administration of fasudil, a selective Rho-kinase inhibitor, for PCI-related refractory myocardial ischemia. Int J Cardiol. 297:8-13,2019. (IF=3.471)

  5. Omura J, Satoh K, Kikuchi N, Satoh T, Kurosawa R, Nogi M, Ohtsuki T, Al-Mamun ME, Siddique MAH, Yaoita N, Sunamura S, Miyata S, Hoshikawa Y, Okada Y, Shimokawa H. ADAMTS8 promotes the development of pulmonary arterial hypertension and right ventricular failure -A possible novel therapeutic target- Circ Res. 125:884-906,2019. (IF=15.862)（10月15日プレスリリース）

  6. Ohtsuki T, Satoh K, Shimizu T, Ikeda S, Kikuchi N, Satoh T, Kurosawa R, Nogi M, Sunamura S, Yaoita N, Omura J, Aoki T, Tatebe S, Sugimura K, Takahashi J, Miyata S, Shimokawa H. Identification of adipsin as a novel prognostic biomarker in patients with coronary artery disease. JAHA. 2019;8:e013716. (IF=4.660)

  7. Siddique MAH, Satoh K, Kurosawa R, Kikuchi N, Elias-Al-Mamun M, Omura J, Satoh T, Nogi M, Sunamura S, Miyata S, Ueda H, Tokuyama H, Shimokawa H. Identification of emetine as a therapeutic agent for pulmonary arterial hypertension -A novel effect of an old drug- Arterioscler Thromb Vasc Biol. 39:2367-2385,2019. (IF=6.618)（10月10日プレスリリース）

  8. Suda A, Takahashi J, Hao K, Kikuchi Y, Shindo T, Ikeda S, Sato K, Sugisawa J, Matsumoto Y, Miyata S, Sakata Y, Shimokawa H. Coronary functional abnormalities in patients with angina and non-obstructive coronary artery disease. J Am Coll Cardiol. 74:2350-2360,2019. (IF=18.639)（11月7日プレスリリース）

  9. Nochioka K, Sakata Y, Miura M, Shiroto T, Takahashi J, Saga C, Ikeno Y, Shiba N, Shinozaki T, Sugi M, Nakagawa M, Komaru T, Kato A, Nozaki E, Iwabuchi K, Hiramoto T, Inoue K, Ohe M, Tamaki K, Tsuji I, Shimokawa H. Impaired glucose tolerance and albuminuria in patients with chronic heart failure: a subanalysis of the SUPPORT trial. ESC Heart Fail. 6:1252-1261,2019. (IF=3.407)

  10. Oikawa T, Sakata Y, Nochioka K, Miura M, Abe R, Kasahara S, Sato M, Aoyanagi H, Saga C, Ikeno Y, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H, the CHART-2 Investigators. Association between temporal changes in C-reactive protein levels and prognosis in patients with previous myocardial infarction. -A report from the CHART-2 Study- Int J Cardiol. 293:17-24,2019. (IF=3.471)

  11. Akizuki M, Sugimura K, Aoki T, Kakihana T, Tatebe S, Yamamoto S, Sato H, Satoh K, Shimokawa H, Kohzuki M. Usefulness of ventilatory gas analysis for the non-invasive evaluation of the severity of chronic thromboembolic pulmonary hypertension. Int J Cardiol. 296:149-154,2019. (IF=3.471)

  12. Tsutsui H, Momomura S, Yamashina A, Shimokawa H, Kihara Y, Saito Y, Hagiwara N, Ito H, Yano M, Yamamoto K, Ako J, Inomata T, Sakata Y, Tanaka T, Kawasaki Y, the J-SHIFT study investigators. Efficacy and safety of ivabradine in Japanese patients with chronic heart failure: J-SHIFT Study. Circ J. 83:2049-2060,2019. (IF=3.025)

  13. Kurosawa R, Satoh K, Kikuchi N, Kikuchi H, Saigusa D, Mamun MEA, Siddique MAH, Omura J, Satoh T, Sunamura S, Nogi M, Numano K, Miyata S, Uruno A, Kano K, Doi T, Aoki J, Oshima Y, Yamamoto M, Shimokawa H. Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension -High-throughput screening of 5,562 compounds- Circ Res. 125:309-327,2019. (IF=15.862)（6月27日、プレスリリース）

  14. Ammirati E, Veronese G, Brambatti M, Merlo M, Cipriani M, Potena L, Sormani P, Aoki T, Sugimura K, Sawamura A, Okumura T, Pinney S, Hong K, Shah P, Braun O, Van de Heyning CM, Montero S, Petrella D, Huang F, Schmidt M, Raineri C, Lala A, Varrenti M, Foa A, Ceccarelli A, Gentile P, Artico J, Agostini V, Patel R, Garascia A, Van Craenenbroeck EM, Hirose K, Isotani A, Arita Y, Fabris E, Hashem S, Garcia-Hernando V, Oliva F, Shimokawa H, Sinagra G, Adler ED, Frigerio M, Camici PG. Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 74:299-311,2019. (IF=18.639)

  15. Sakuma I, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H. Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis. Heart Vessels. 34:1839-1851,2019. (IF=1.620)

  16. Ikeda S, Mukai R, Mizushima W, Zhai P, Oka SI, Nakamura M, Del Re DP, Sciarretta S, Hsu CP, Shimokawa H, Sadoshima J. Yes-associated protein (YAP) facilitates pressure-overload induced dysfunction in the diabetic heart. JACC Basic Transl Sci.4:611-622,2019. (IF=3.696)

  17. Oikawa T, Sakata Y, Nochioka K, Miura M, Abe R, Kasahara S, Sato M, Aoyanagi H, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H: the CHART-2 Investigators. Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation -A report from the CHART-2 Study- Int J Cardiol. 290:106-112,2019. (IF=3.471)

  18. Hasebe Y, Fukuda K, Nakano M, Kumagai K, Karibe A, Fujishima F, Satake H, Kondo M, Wakayama Y, Shimokawa H. Characteristics of ventricular tachycardia and long-term treatment outcome in patients with dilated cardiomyopathy complicated by Lamin A/C gene mutations. J Cardiol. 74:451-459,2019. (IF=2.289)

  19. Miki K, Nakano M, Aizawa K, Hasebe Y, Kimura Y, Morosawa S, Akashi T,Morishita Y, Miyata S, Fukuda K, Shimokawa H. Risk factors and localization of silent cerebral infarction in patients with atrial fibrillation. Heart Rhythm. 16:1305-1313,2019. (IF=2.289)

  20. Suzuki K, Oikawa T, Nochioka K, Miura M, Kasahara S, Sato M, Aoyanagi H,Shiroto T, Takahashi J, Miyata S, Sakata Y, Shimokawa H. Elevated serum non-HDL cholesterol and triglyceride levels as residual risks for myocardial infarction recurrence under statin treatment. Arterioscler Thromb Vasc Biol. 39:934-944,2019. (IF=6.618)

  21. Sato K, Takahashi J, Odaka Y, Suda A, Sueda S, Terakawa H, Ishii K, Kiyooka Y, Hirayama A, Sumiyoshi T, Tanabe Y, Kimura K, Kaikita K, Ong P, Sechtem U, Camici PG, Kaski JC, Crea F, Beltrame JF, Shimokawa H; on behalf of the Japanese Coronary Spasm Association. Clinical characteristics and long-term prognosis of contemporary patients with vasospastic angina -Ethnic differences detected in an international comparative study- Int J Cardiol. 291:13-18,2019. (IF=3.471)

  22. Amamizu H, Matsumoto Y, Morosawa S, Ohyama K, Uzuka H, Hirano M, Nishimiya K, Gokon Y, Watanabe-Asaka T, Hayashi M, Miyata S, Kamei T, Kawai Y, Shimokawa H. Cardiac lymphatic dysfunction causes drug-eluting stent-induced coronary hyperconstricting responses in pigs in vivo. Arterioscler Thromb Vasc Biol. 39:741-753,2019. (IF=6.618)（プレスリリース、3月29日）

  23. Yoshida M, Nakamichi T, Mori T, Kenta Ito K, Shimokawa H, Ito S. Low-energy extracorporeal shock wave ameliorates ischemic acute kidney injury in rats. Clin Exp Nephrol. (IF=1.971)

  24. Nishimiya K, Yin B, Piao Z, Ryu J, Osman H, Leung HM, Sharma G, Liang CP, Gardecki JA, Zheng H, Shimokawa H, Tearney GJ. Micro-optical coherence tomography for endothelial cell visualization in the coronary arteries. JACC Imaging. 12:1878-1880,2019. (IF=10.975)

  25. Ito A, Shiroto T, Godo S, Saito H, Tanaka S, Ikumi Y, Kajitani S, Satoh K, Shimokawa H. Important roles of endothelial caveolin-1 in endothelium-dependent hyperpolarization and ischemic angiogenesis in mice. Am J Physiol. 316:H900-910,2019. (IF=4.048)

  26. Kasahara S, Sakata Y, Nochioka K, Miura M, Abe R, Sato M, Aoyanagi H, Fujihashi T, Yamanaka S, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H: the SUPPORT Investigators. Conversion formula from B-type natriuretic peptide to N-terminal proBNP values in patients with chronic heart failure. Int J Cardiol. 280:184-189,2019. (IF=3.471)

  27. Abe R, Sakata Y, Nochioka K, Miura M, Oikawa T, Kasahara S, Sato M, Aoyanagi H, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H; the CHART-2 Investigators. Gender differences in prognostic relevance of self-care behaviors on mortality and hospitalization in patients with heart failure -A report from the CHART-2 Study- J Cardiol. 73:370-378,2019. (IF=2.289)

  28. Morosawa S, Yamamoto H, Hirano M, Amamizu H, Uzuka H, Ohyama K, Hasebe Y, Nakano M, Fukuda K, Takayama K, Shimokawa H. Development of a shock-wave catheter ablation system for ventricular tachyarrhythmias: Validation study in pigs in vivo- J Am Heart Assoc. 2019 Jan 22;8(2):e011038. doi: 10.1161/JAHA.118.011038. (IF=4.660)

  29. Ikeda S, Mizushima W, Sciarretta S, Abdellatif M, Zhai P, Mukai R, Fefelova N, Oka S, Nakamura M, Del Re DP, Farrance I, Park JY, Tian B, Xie LH, Kumar M, Hsu CP, Sadayappan S, Shimokawa H, Lim DS, Sadoshima J. Hippo deficiency leads to cardiac dysfunction accompanied by cardiomyocyte dedifferentiation during pressure overload. Circ Res. 124(2):292-305,2019. (IF=15.862)

  30. Kasahara S, Sakata Y, Nochioka K, Tay WT, Claggett B, Abe R, Oikawa T, Sato M, Aoyanagi H, Miura M, Shiroto T, Takahashi J, Sugimura K, Teng K, Miyata S, Shimokawa H. The 3A3B score: The simple risk score for heart failure with preserved ejection fraction -A report from the CHART-2 Study- Int J Cardiol. 284:42-49,2019. doi: 10.1016/j.ijcard.2018.10.076. (IF=4.034)

  31. Hao K, Takahashi J, Sakata Y, Miyata S, Shiroto T, Nochioka K, Miura M, Oikawa T, Abe R, Sato M, Kasahara S, Aoyanagi H, Shimokawa H; the CHART-2 Investigators. Prognostic impact of residual stenosis after percutaneous coronary intervention in patients with ischemic heart failure -A report from the CHART-2 study- Int J Cardiol. 278:22-27,2019. (IF=3.471)